CEVAC CEVAC BROILER ND K / 5000 doses

Size: px
Start display at page:

Download "CEVAC CEVAC BROILER ND K / 5000 doses"

Transcription

1 CEVAC BROILER ND K / 5 doses

2 CEVAC BROILER ND K Newcastle disease a permanent threat Newcastle Disease is highly contagious and exists in a wide range of forms. It is one of the four major poultry diseases worldwide. It takes its toll in all areas where poultry farming is intensive and spreads practically everywhere. Despite health control programmes and extensive vaccination, Newcastle Disease is enzootic in all continents, and also epizootic in many of the world regions. In epizootic situations, it is recommended to combine a live vaccine with an inactivated one to actively immunise young chicks from 1 day old onwards. To achieve this goal, CEVA SANTE ANIMALE offers the high technology vaccine:. Confirmed outbreaks of velogenic Newcastle Disease in 2-21

3 n outstanding, efficient and innovative technology Innovative An exceptional balance CEVA SANTE ANIMALE's formulation expertise enables to combine a high antigenic concentration with a small volume (.1ml). Beyond the small volume of the dose and its antigenic concentration, also has exceptional fluidity, making it easy to inject, and is perfectly tolerated at the injection site. VACCINE The Best in its generation VISCOSITY at 5 C and 12 rpm (in mpas) A 48.3 B 51.3 Combined inactivated vaccine 8-11 A et B : competitors Oily phase Aqueous phase Vaccine antigens Conventional inactivated vaccine.1 ml / dose is totally safe 34.2

4 formulation Effective inactivation process Inactivation is one of the key steps in the inactivated vaccine manufacturing process. The objective is to neutralise or kill the virus by removing its capacity to replicate itself, while maintaining its antigenic characteristics. Binary Ethylene Imine (BEI) has been selected as inactivation agent for the CEVAC K inactivated range. Unlike other inactivation agents such as formaldehyde, BEI neutralises the virus by acting on its nucleic acids without modifying its antigenic structure.** offers the best antigenic quality for a better immune response BEI Inactivation Formaldehyde Destruction of ADN or RNA, but no modification of surface antigens. Denaturation of surface antigens simple to use Intramuscular or subcutaneous is remarkably easy to use both intramuscularly and subcutaneously. It can be administered bothwith automatic injection systems and manual syringes. Manual injection Manual vaccination practices are similar to those employed for the vaccination of future layers or future breeders via the subcutaneous or intramuscular route. Automatic vaccination systems Automatic vaccination systems are in most cases set up in the hatchery, enabling fast, accurate injection of all types of vaccine into 1-day-old chicks. They carry out sub cutaneous or intramuscular injection using interchangeable syringes that cannot be deregulated. **Buonavoglia C et al 1988 Veterinary Research Communications, 12,2-3 :

5 n outstanding, efficient and innovative technology % protection Challenge 3 weeks Strenghten your protection from 1 day old onwards 25 offers the best protection in the face of high viral challenge. The combination of injected at one day old, with an attenuated live vaccine, produces protection and antibody levels that are significantly higher than those reached from the use of each vaccine individually. This combined vaccination is especially suitable for epidemiological situations where the risks of infection are high.* 5 Challenge 6 weeks + CEVAC Vitapest L Comparison of protection (%) in a virulent ND challenge to commercial chickens at 3 and 6 weeks given by alone and in combination with CEVAC Vitapest L (Ceva 2). % of protection A B C * Bennejean G, Avian Pathology, 7 : Mean HI titre (log2) Age (days) + CEVAC Vitapest L Mean ND titres observed after vaccination with alone or in combination with CEVAC Vitapest L in commercial chicks vaccinated at 1 day of age (Ceva 2) guarantees a highly significant, lasting protection and serological response, up to 5 days old, that exceed those of its competitors. % protection Unvaccinated controls Live vaccine Inactivated vaccine Live + inactivated vaccines Âge (days) Evolution of protection procured by live and inactivated vaccines administered individually or combined, to 1-day-old commercial chicks (Bennejean et al., 1978). Efficacy to withstand any challenge 21 days 28 days 42 days Comparison of the (%) protection procured by and that of 3 competitor vaccines (A, B, C) against virulent challenge at 21, 28 and 42 days in commercial chicks (Ceva 21). Mean HI titre (log2) Âge (days) A B C Average ND antibody rates after vaccination with or 3 competitor vaccines (A, B, C) in commercial chicks (Ceva 21).

6 Cevac Broiler ND K Vaccination programmes These vaccination programmes are given for information only and should be adapted to the local epidemiological context, the local choices for implementation and according to the other vaccinations that have already been recommended. Age Vaccines Route 1 day old in the hatchery Cevac Broiler ND K + Cevac Vitapest L On farms, Cevac Broiler ND K can be injected from 1 to 7 days old. IM or SC for.1 ml Spray Live vaccines are ideally combined with inactivated vaccines in one-day-olds in the hatchery. In cases where injection cannot be carried out in the hatchery, the recommended age limit is 7 days old. It is important that the inactivated vaccine is administered in the same week as the live one. The other vaccinations against Newcastle Disease using live vaccines remain unchanged. Efficacy to stand any test from one day old Remarkably easy to use Totally safe in young chicks Exceptional antigenic quality COMPOSITION: contains La Sota strain of Newcastle Disease virus in inactivated form, homogenized with oily adjuvant and merthiolate as a preservative. INDICATIONS: is recommended for the vaccination of young chickens, especially dayold chicks, against Newcastle Disease (ND). can be used alone or together with a live ND vaccine. ADMINISTRATION AND DOSAGE: should be injected subcutaneously (under the skin of the neck) or by intramuscular route (thigh muscles) at the dose of.1 ml per bird. GENERAL PRECAUTION: Satisfactory protection can be achieved in healthy birds only. Use sterile injection equipment. Keep the vaccine at room temperature (15 to 25 C) for 3 to 4 hours before use. Shake the bottle well before and during use. Check the accuracy of the syringe to ensure that the correct dose is delivered. Once a bottle has been opened, its content must be used up within 24 hours; otherwise, it should be discarded. WARNING: If the vaccine is accidentally injected to the operator, urgent medical attention is required. STORAGE: between 2 C and 8 C protected from light, do not freeze. PRESENTATION: plastic vials of ml ( doses) and 5 ml (5 doses). CEVAC AVIAN BIOLOGICAL RANGE CEVA SANTE ANIMALE S.A. - La Ballastière - B.P Libourne Cedex - France - Tél. 33 () Fax 33 () contact@ceva.com -

ESSENTIAL PROTECTION

ESSENTIAL PROTECTION ESSENTIAL PROTECTION for better life BROILER ND K VITABRON L VITAPEST L NEW L Supported by C H I C K P R O G R A M CONVENTIONAL vaccine range against Newcastle Disease CEVA HATCHERY I MMUNIZATION CONTROL

More information

TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE. Unique combination vaccines to protect against Coryza and Salmonella. Supported by CEVAC CORYMUNE 4K

TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE. Unique combination vaccines to protect against Coryza and Salmonella. Supported by CEVAC CORYMUNE 4K CEVAC CORYMUNE RANGE Unique combination vaccines to protect against Coryza and Salmonella TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE Supported by CEVAC CORYMUNE 4K Unique broad combination vaccine against

More information

CevaC Mass L THe Ceva Mass solution

CevaC Mass L THe Ceva Mass solution CevaC Mass L THe Ceva Mass solution Ceva Santé Animale S.A. - 10, av. de la Ballastière - BP 126-33500 Libourne Cedex - France Tel : + 33 5 57 55 40 40 - Fax : + 33 5 57 55 41 92 www.ceva.com CEVAC MASS

More information

Vectormune ND a step towards control of Newcastle Disease

Vectormune ND a step towards control of Newcastle Disease Poultry Vaccinology Summit April 28-30, Budapest, Hungary Vectormune ND a step towards control of Newcastle Disease Yannick Gardin 1, Vilmos Palya 1, John Elattrache 1, Marcelo Paniago 2, Christophe Cazaban

More information

making LT protection safer and easier

making LT protection safer and easier making LT protection safer and easier 1 vaccine up to 3 immunities 4 Vectormune FP-LT and. Vectormune FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from

More information

Ceva s offer to optimize performance Simpler vaccination and better safety

Ceva s offer to optimize performance Simpler vaccination and better safety Ceva s offer to optimize performance Simpler vaccination and better safety Rick van Oort Poultry Corporate Range Manager Layer range CEVA Sante Animale Bangkok-Thailand March 12, 2013 Bodyweight (g) 1600

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza

More information

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State) DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis OR inac emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.25

More information

RECOMBINANT VACCINES Live or Killed

RECOMBINANT VACCINES Live or Killed Antigens and Vaccines Molecular biology drives Innovation Antigen Gene of Interest Recombination RECOMBINANT VACCINES Live or Killed Antigens and Vaccines Molecular biology drives Innovation Antigen Gene

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection

More information

Summary of Product Characteristics

Summary of Product Characteristics Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Novamune concentrate and solvent for suspension for injection for chickens 2 QUALITATIVE

More information

Suggestions to prevent / control Respiratory Disease Complex in poultry

Suggestions to prevent / control Respiratory Disease Complex in poultry Suggestions to prevent / control Respiratory Disease Complex in poultry Dr. J. L. Vegad Adviser Phoenix Group 201/15, Gorakhpur, Jabalpur - 482001 Introduction Today, respiratory disease complex has emerged

More information

Dr.Christophe Cazaban

Dr.Christophe Cazaban Dr.Christophe Cazaban Technical Manager Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated from the French Veterinary University of Lyon in 1993 He completed his education with

More information

NEWCASTLE KILLED VACCINES IN BROILERS

NEWCASTLE KILLED VACCINES IN BROILERS Issue No.24 / May 2009 T H E B E N E F I T S O F NEWCASTLE KILLED VACCINES IN BROILERS Dr Vincent TURBLIN Deputy Regional Market Manager Poultry CEVA Animal Health Asia Pacific Selangor, Malaysia Newcastle

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis Influenza H5N2 emulsion for injection for chickens. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose

More information

WPSA & WVPA Scientific Conference Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia

WPSA & WVPA Scientific Conference Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia WPSA & WVPA Scientific Conference 2013 Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia Outlook the presentation Major changes in the Asia Poultry Industry

More information

General context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015

General context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015 Modeling the effectiveness of avian influenza vaccination strategies in Bangladesh: evaluation of the added value of day old chick vaccination in hatcheries General context and objectives of the project

More information

YOU THINK INFLUENZA IS FATAL? THINK AGAIN.

YOU THINK INFLUENZA IS FATAL? THINK AGAIN. YOU THINK INFLUENZA IS FATAL? THINK AGAIN. HVT vector vaccine for H5 Avian Influenza protection Avian influenza Avian influenza remains a major threat for the global poultry industry. Among the different

More information

Evaluation of an effervescent tablet presentation of a live attenuated Newcastle Disease vaccine in laboratory and field conditions

Evaluation of an effervescent tablet presentation of a live attenuated Newcastle Disease vaccine in laboratory and field conditions Evaluation of an effervescent tablet presentation of a live attenuated Newcastle Disease vaccine in laboratory and field conditions Andrea Delvecchio 1, Thomas Delquigny 1, Jean-Bernard Herin 1, Jean-Claude

More information

2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France

2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France Dr. Sylvain Comte Poultry Corporate Marketing Director Ceva Sante Animale, France Graduated as a Veterinary in 1993 from National Veterinary School of Nantes France Master of science in Physiology and

More information

ANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE

ANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE ANSES Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP 90203 35302 FOUGERES CEDEX FRANCE DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT

More information

Is Newcastle disease still a threat for the poultry industry?

Is Newcastle disease still a threat for the poultry industry? Is Newcastle disease still a threat for the poultry industry? Marcelo PANIAGO Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Newcastle Disease in the world Newcastle

More information

SCIENTIFIC DISCUSSION EMEA/V/C/036. Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands. N/a

SCIENTIFIC DISCUSSION EMEA/V/C/036. Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands. N/a SCIENTIFIC DISCUSSION Product name: Nobilis IB 4-91 Procedure No.: EMEA/V/C/036 Applicant company : Active substances and strengths: (ATCvet code) Proposed International Non-proprietary Name: Intervet

More information

Director Biology Innovation Strategy Department. Ceva Sante Animale, France

Director Biology Innovation Strategy Department. Ceva Sante Animale, France Dr.Yannick Gardin Director Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated as a Doctor in Veterinary Medicine, from Veterinary School of Lyon France 1977 : Join Ceva as Technical

More information

Technical meeting 4-6 December 2013 Beijing

Technical meeting 4-6 December 2013 Beijing Technical meeting 4-6 December 2013 Beijing Review on cost and financial implications of HPAI vaccination in countries applying HPAI vaccination Jan Hinrichs, Animal Health Economist, FAO Bangkok jan.hinrichs@fao.org

More information

Ceva HAND book of poultry diseases

Ceva HAND book of poultry diseases IVAN DINEV & CEVA Volume 1 Ceva HAND book of poultry diseases GUMBORO CHICKEN ANaEMIA REOVIRUS MAREK RUNTING-STUNTING SYNDROME NEWCASTLe DISEASE AVIAN INFLUENZA INFECTIOUS BRONCHITIS LARyNGOTRACHEITIS

More information

PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between

PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between Dr. Marc Prikazsky, Chairman and Chief Executive Officer and Prof. Ren Tao, Vice-Dean

More information

Comparative immunogenicity of fowl cholera vaccine in Jinding ducks

Comparative immunogenicity of fowl cholera vaccine in Jinding ducks The Bangladesh Veterinarian (2013) 30(2) : 41-45 Comparative immunogenicity of fowl cholera vaccine in Jinding ducks S Sultana, S Saha and MM Amin* 1 Department of Microbiology and Hygiene, Faculty of

More information

investing our GLOBAL RESOURCES FUTURE of in the POULTRY We ll be thereṭm

investing our GLOBAL RESOURCES FUTURE of in the POULTRY We ll be thereṭm investing our GLOBAL RESOURCES in the FUTURE of POULTRY We ll be thereṭm 2 As the world has become interconnected, the need for a global perspective to animal health has never been more important. An outbreak

More information

Optimization for Chick Performance Bangkok, Thailand 12 th March 2013

Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Marcelo PANIAGO, DVM, MSc, MBA Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Evolution of the

More information

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENCEFAL-VAC Live lyophilised vaccine for chickens 2. QUALITATIVE AND QUANTITATIVE

More information

Rotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ

Rotavec Corona Emulsion for injection for cattle. Introduction. Company name: MSD Animal Health. Address: Walton Manor. Walton. Milton Keynes MK7 7AJ Rotavec Corona Emulsion for injection for cattle Introduction Company name: MSD Animal Health Address: Walton Manor Walton Milton Keynes MK7 7AJ Telephone: 01908 685685 (Customer Support Centre) Fax: 01908

More information

Press Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection

Press Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection Press Pack Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection Content 1) Summary 2) Definition of the vaccine 3) Safety 4) Efficacy 5) Additional advantages 6) Vectormune

More information

«Together we are building a new reference to create value beyond animal health»

«Together we are building a new reference to create value beyond animal health» Ceva in key figures... Sales 2010: 468 million (v 2009 395 million) Annualgrowth: 18.5% - R&D expenditure: 9% of sales Number of employees: 2543 Present: 40 countries - R&D centers 11 - Production sites

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB 4-91 lyophilisate for suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of

More information

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State) DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

Molecular diagnosis of infectious bronchitis: recent developments. Richard Currie

Molecular diagnosis of infectious bronchitis: recent developments. Richard Currie Molecular diagnosis of infectious bronchitis: recent developments Richard Currie The infectious bronchitis virus RNA (nucleic acid) on the inside the genetic finger print Proteins (S1 and S2 spike proteins)

More information

Because of the high quality of its contents and the low volume injected, Lapinject VHD can be used safely from

Because of the high quality of its contents and the low volume injected, Lapinject VHD can be used safely from HaeMORRHAGIC DISEASE It is supported by a recent document, which used the latest scientific research available on Viral Haemorrhagic Disease (VHD) and where it met the most rigorous requirements in terms

More information

Research note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2

Research note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2 Research note Monitoring of vaccine take by quantitative realtime polymerase chain reaction following different Marek s disease vaccination programs in future broiler breeders Delvecchio A. 1, Gimeno I.

More information

Immunity and Poultry Health (3)

Immunity and Poultry Health (3) Understanding vaccines and vaccination programmes Protecting the health of poultry through vaccination has been an essential part of poultry production for more than 50 years. Vaccination is the final

More information

Etiology. Paramyxovirus type 1 = Newcastle disease.

Etiology. Paramyxovirus type 1 = Newcastle disease. Newcastle Disease Many strains of similar virus cause signs ranging from mild respiratory signs (pneumotropic) with low mortality to severe neurological (neurotropic) and/or visceral lesions (viscerotropic)

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 30/06/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Poultry Disease Manual Characteristics And

Poultry Disease Manual Characteristics And Poultry Disease Manual Characteristics And Control Of Infections Written by: Dr. Jacquie Jacob, University of Kentucky Pullorum disease, also called Infection by Salmonella pullorum has also been reported

More information

IMMUNOGENICITY OF FORMALDYDE INACTIVATED NEWCASTLE DISEASE VIRUS FIELD ISOLATE IN MATERNAL ANTIBODY FREE CHICKENS

IMMUNOGENICITY OF FORMALDYDE INACTIVATED NEWCASTLE DISEASE VIRUS FIELD ISOLATE IN MATERNAL ANTIBODY FREE CHICKENS IMMUNOGENICITY OF FORMALDYDE INACTIVATED NEWCASTLE DISEASE VIRUS FIELD ISOLATE IN MATERNAL ANTIBODY FREE CHICKENS Anak Agung Ayu Mirah Adi 1 *, IGusti Agung Arta Putra 2, Nyoman Mantik Astawa 3, I Made

More information

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1 Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1 PACKAGE LEAFLET Rispoval IBR-Marker Vivum Lyophilisate and diluent for suspension for injection for cattle. 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION

More information

Vaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013

Vaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 Vaccines of today and products needed for the short-, intermediate- and longterm XU, Wei-Cheng OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 1 Influenza A reservoir & transmission H3N8, (H5N1)

More information

Vaccination to stop transmission

Vaccination to stop transmission Vaccination to stop transmission Arjan Stegeman j.a.stegeman@uu.nl Faculty of Veterinary Medicine Goals of vaccination To prevent clinical disease (production, animal welfare, treatment costs, antimicrobial

More information

AVIAN ENCEPHALOMYELITIS- FOWL POX-PIGEON POX VACCINE

AVIAN ENCEPHALOMYELITIS- FOWL POX-PIGEON POX VACCINE AVIAN ENCEPHALOMYELITIS- FOWL POX-PIGEON POX VACCINE Avian Encephalomyelitis Fowl Pox Pigeon Pox Vaccine is a chicken embryo propagated, freeze-dried, vaccine for wing web administration in chickens. The

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1

More information

PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE

PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE Acta Veterinaha Hungahca 48 (4), pp. 443-454 (2000) PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE Maria KELEMEN'*, KatalinFORGACH 1, JuditlVAN 2, V.

More information

Avian Infectious Bronchitis Vaccine, Inactivated

Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated consists of an emulsion or a suspension of one or more serotypes of avian infectious bronchitis virus which

More information

The FIRST intradermal M Hyo vaccine

The FIRST intradermal M Hyo vaccine The FIRST intradermal M Hyo vaccine Effective, safe and animal friendly in a single dose Porcilis M Hyo ID Once Take the leap forward with easy-to-use needle free vaccinations Porcilis M Hyo ID Once One

More information

Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil

Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil Countries with endemic velogenic Newcastle Disease (ND) in Latin America Mexico Guatemala Belize

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BIOCOM P Vet, suspension for injection for minks (all MS except DK) BIOVAC-BP, suspension for injection for minks (DK) 2.

More information

Gumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands

Gumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro Disease: where are we with IBDV epidemiology J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: 2 segments of dsrna Non enveloped virus

More information

ODXJPVID July 2013

ODXJPVID July 2013 SUMMER 2013 ODXJPVID.13 17 July 2013 d e TABLE OF CONTENTS 1 History 2 in Brief 3 Routes of Vaccination 4 Instructions for Storage and Use of Vaccines 5 Precautions 6 List of s Large Animal Vaccines 6

More information

VACCINES FOR VETERINARY USE Vaccina ad usum veterinarium

VACCINES FOR VETERINARY USE Vaccina ad usum veterinarium EUROPEAN PHARMACOPOEIA 6.0 Vaccines for veterinary use out,theexpirydateforthefinallotiscalculatedfromthe date of an approved stability-indicating test or failing this fromthedateoffreeze-dryingorthedateoffillingintothe

More information

G. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K.

G. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K. J. Comp. Path. 1986 vol. 96 OBSERVATIONS ON THE ABILITY OF AVIAN REOVIRUS VACCINMATION OF HENS TO PROTECT THEIR PROGENY AGAINST THE EFFECTS OF CHALLENGE WITH HOMOLOGOUS AND HETEROLOGOUS STRAINS By G. W.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Part I.B page 1 of 7 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/7 Part I.B page 2 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PCV emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Ducat (DE: Nobivac RC, SE : Nobivac Ducat vet.) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Per

More information

MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS 8, rue Claude Bourgelat Parc d'activités de la Grande Marche CS 70611 35306 Fougères FRANCE MUTUAL RECOGNITION PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT

More information

DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S.

DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S. DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S. Gallinarum TESTED BY Salmonella Enteritidis AND Salmonella Gallinarum CHALLENGES, 11 WEEKS AFTER VACCINATION József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva

More information

INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS)

INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS) INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS) AVIAN ADENOVIRUSES (CHICKEN ADENOVIRUSES, FADV) Adenoviruses are common in poultry. Many replicate in healthy birds without

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Versifel FeLV, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

AviagenBrief. Marek s Disease Control in Broiler Breeders

AviagenBrief. Marek s Disease Control in Broiler Breeders AviagenBrief January 2018 Marek s Disease Control in Broiler Breeders Author: A. Gregorio Rosales DVM, MS, PhD, DACPV - Poultry Health Consultant Introduction Marek s Disease Virus (MDV), a highly infectious

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1) NAME OF THE MEDICINAL PRODUCT Meningococcal A conjugate vaccine 5 micrograms, Lyophilized Brand name- MenAfriVac 2) QUALITATIVE AND QUANTITATIVE COMPOSITION After

More information

ISSN: (Print) (Online) Journal homepage:

ISSN: (Print) (Online) Journal homepage: Veterinary Quarterly ISSN: 01652176 (Print) 18755941 (Online) Journal homepage: https://www.tandfonline.com/loi/tveq20 Comparison of the effect of live Newcastle disease vaccine Clone 30 in broilers administered

More information

The Review of Newcastle Disease Live Vaccines Application. By: M. Abdoshah

The Review of Newcastle Disease Live Vaccines Application. By: M. Abdoshah The Review of Newcastle Disease Live Vaccines Application By: M. Abdoshah Introduction Only one serotype (PMV1) Maternally derived antibodies are protective All vaccines are efficacious Is vaccine protection

More information

Implications and implementation of dayold chick vaccination

Implications and implementation of dayold chick vaccination Implications and implementation of dayold chick vaccination FAO technical meeting Beijing, 3 December 2013 Sophie von Dobschuetz On behalf of the meeting participants 1 Meeting background and objectives

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval 3 BRSV Pi3 BVD Lyophilisate and suspension for suspension for injection for cattle 2. QUALITATIVE AND QUANTITATIVE

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AFTOVAXPUR DOE emulsion for injection for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ProteqFlu-Te Suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose contains:

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 25/01/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and strains within

More information

Limitation of the spread and impact of infectious coryza through the use of a continuous disinfection programme

Limitation of the spread and impact of infectious coryza through the use of a continuous disinfection programme Onderstepoort Journal of Veterinary Research, 7: 8 () Limitation of the spread and impact of infectious coryza through the use of a continuous disinfection programme R.R. RGG Department of Microbial, iochemical

More information

Vet Caress. VETERINARY CARE SERVICES Vaccines and Vaccination

Vet Caress. VETERINARY CARE SERVICES Vaccines and Vaccination Vet Caress VETERINARY CARE SERVICES s and Vaccination By Dr Atiqullah Khan (DVM) KEYWORDS: VACCINE, TYPES OF VACCINE, DIFFERENT BETWEEN LIVE AND KILLED VACCINE, VACCINATION SCEDULES. A.:- is a preparation

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Circovac emulsion and suspension for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Evaluation of Two Vaccination Schemes Using Live Vaccines against Newcastle Disease in Chickens

Evaluation of Two Vaccination Schemes Using Live Vaccines against Newcastle Disease in Chickens Turk. J. Vet. Anim. Sci. 2007; 31(3): 165-169 TÜB TAK Research Article Evaluation of Two Vaccination Schemes Using Live Vaccines against Newcastle Disease in Chickens Mansur-ud-Din AHMAD 1, *, Mamoona

More information

Beurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Poulvac IB Primer

Beurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Poulvac IB Primer Beurteilungsbericht zur Veröffentlichung (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Zulassungsdatum: 06.03.2000 Zulassungsnummer: 167a/88 Datum der Erstellung des öffentlichen Beurteilungsberichts: 15.05.2013

More information

The development of avian influenza vaccines for emergency use

The development of avian influenza vaccines for emergency use 11 The development of avian influenza vaccines for emergency use T.R. Mickle, D.E. Swayne, and N. Pritchard Abstract Costly outbreaks of mildly and highly pathogenic avian influenza (AI) have occurred

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 28/02/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and

More information

VETERINARY SERVICES POLICY STATEMENT

VETERINARY SERVICES POLICY STATEMENT ASTRAL OPERATIONS LTD VETERINARY SERVICES POLICY STATEMENT I, the undersigned, CEO of Astral Operations Ltd, am committed to a policy of continuous improvement of poultry health and food safety and will

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis ND Clone 30 live 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: per dose * Live Newcastle disease virus, strain Clone 30 ³ 6.0 log 10 ELD

More information

Written by Dr. Rodrigo A. Espinosa, Aviagen Regional Technical Service Veterinarian for North America and Latin America

Written by Dr. Rodrigo A. Espinosa, Aviagen Regional Technical Service Veterinarian for North America and Latin America AviagenBrief November 2016 Bacterin Usage Written by Dr. Rodrigo A. Espinosa, Aviagen Regional Technical Service Veterinarian for North America and Latin America SUMMARY A good vaccination program, along

More information

by Dr Thijs van Dijk and Anna-Christina Riebau Marketing Poultry Vaccines, Lohmann Animal Health

by Dr Thijs van Dijk and Anna-Christina Riebau Marketing Poultry Vaccines, Lohmann Animal Health Gumboro vaccination a matter of timing ive IBD vaccines are categorised by their break- titre, virulence and Lthrough potential to induce immune suppression, into mild, intermediate and intermediate plus.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax Rabies suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle Rispoval IBR-Marker Live (for

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON USER SAFETY FOR IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON USER SAFETY FOR IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS European Medicines Agency Veterinary Medicines and Inspections London, 23 April 2007 Doc. Ref. EMEA/CVMP/IWP/54533/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON USER SAFETY

More information

An outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya

An outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya An outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya S.O. Al-GARIB*, A. A. ASHEG, A. KAMMON and M.A. HAMID Department of Poultry Disease, Faculty of Veterinary

More information

ASEAN STANDARDS FOR ANIMAL VACCINES

ASEAN STANDARDS FOR ANIMAL VACCINES Adopted at the 40 th AMAF 11 October 2018 Ha Noi, Viet Nam ASEAN Cooperation in Food, Agriculture and Forestry ASEAN STANDARDS FOR ANIMAL VACCINES Third Edition Li v e s t o c k Publication Series No.2A

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

Updations on the epidemiological situation of Avian Influenza (AI) in Libya. The 11 th JPC REMESA Algiers, Algeria 24-25November2015

Updations on the epidemiological situation of Avian Influenza (AI) in Libya. The 11 th JPC REMESA Algiers, Algeria 24-25November2015 Updations on the epidemiological situation of Avian Influenza (AI) in Libya The 11 th JPC REMESA Algiers, Algeria 24-25November2015 The main issue in Libya right now that; There are non-reported (underestimated

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESPIPORC FLUpan H1N1 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of

More information

PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT PAUL-EHRLICH-INSTITUT Bundesamt für Sera und Impfstoffe Federal Agency for Sera and Vaccines Paul-Ehrlich-Strasse 51-59 63225 Langen Germany MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, August 2014

OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, August 2014 OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, 26-28 August 2014 Animal population Birds Million Animal Million Chicken 249 Cattle 23.34 Duck 47.2 Buffalo 1.45

More information

Her future looks bright

Her future looks bright Her future looks bright ceva rispens vaccines Titre Sous titre Lorem ipsum icam no. Fortusequam ideless itatem quiation con. Ratias vene poreped quamusapicia volupta erspelleni. Flexibilit lorem ipsumnectio

More information

Updated: 26 August 2010

Updated: 26 August 2010 Australian Technical Advisory Group on Immunisation (ATAGI) Updated advice on the use of pandemic and seasonal influenza vaccines in children

More information